0
0
was successfully added to your cart.

September 5, 2018
0

Decision support for developing immune modulation therapeutic

By | | No Comments

Need:

The CEO of a biotech platform technology company needed to assess the strategic fit of its technology in the complement inhibitor space.

Assignment:

MSC was engaged to gather competitive intelligence about inhibitors developed against characterized targets in the immunological cascade to identify development opportunities were the client would have a competitive edge. A shortlist of potential licensees was crafted based on identified drug candidates with technical disadvantages (e.g. short half-life, molecule size, cost of goods, etc.) that the client’s technology would be able to address. The CEO presented the outcome to his board and subsequently used it as a foundation for the company’s collaboration strategy in this space.

September 5, 2018
0

Business opportunity and indication assessment in the dermatology space

By | | No Comments

Need:

A clinical stage pharma company needed to assess it business opportunity for its first topical drug.

Assignment:

MSC performed a high-level indication assessment of two large dermatology indications to determine the client’s strategic fit with current treatment algorithms, physician’s decision trees and prescription patterns on the target markets. Extensive reports were written for each of the indications where drug developing companies along with competitive intelligence about development pipelines, MOAs and recent financial deals were positioned in relation to the client’s envisioned TPP. To verify the strategic fit of the client’s envisioned TPP with the unmet clinical need, interviews were conducted with general physicians at primary wards, dermatologists and patient organizations. Based on the need assessment, competitive landscape and prescription norms, a solid foundation for a business plan could be crafted.